National Health (Pharmaceutical Benefits - Therapeutic Groups) Amendment Determination 2013 (No. 4) (No. PB 77 of 2013)

Link to law: https://www.comlaw.gov.au/Details/F2013L02010

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
PB 77 of 2013
National Health (Pharmaceutical Benefits – Therapeutic Groups) Amendment Determination 2013 (No. 4)
National Health Act 1953
I, FELICITY MCNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 84AG(1) of the National Health Act 1953.
Dated          26     November 2013
 
 
 
 
 
 
 
 
 
 
 
FELICITY MCNEILL
 
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
1              Name of Determination
       (1)     This Determination is the National Health (Pharmaceutical Benefits – Therapeutic Groups) Amendment Determination 2013 (No. 4).
       (2)     This Determination may also be cited as PB 77 of 2013.
2              Commencement
                This Determination commences on 1 December 2013.
 
 
3              Amendments to PB 1 of 2010
Schedule 1 amends the National Health (Pharmaceutical Benefits – Therapeutic Groups) Determination 2010 (PB 1 of 2010).
 
 
Schedule 1             Amendments
 
[1]      Schedule 1, Part 7
  omit:
 
1
Atorvastatin
 
[2]      Schedule 1, Part 8
omit:
 
2
Venlafaxine